Pathogenic_bacteria
Pathogenic_bacteria
Pathogenic bacteria are bacteria that can cause disease.[1] This article focuses on the bacteria that are
pathogenic to humans. Most species of bacteria are harmless and many are beneficial but others can cause Pathogenic bacteria
infectious diseases. The number of these pathogenic species in humans is estimated to be fewer than a
hundred.[2] By contrast, several thousand species are part of the gut flora present in the digestive tract.
The body is continually exposed to many species of bacteria, including beneficial commensals, which grow
on the skin and mucous membranes, and saprophytes, which grow mainly in the soil and in decaying matter.
The blood and tissue fluids contain nutrients sufficient to sustain the growth of many bacteria. The body has
defence mechanisms that enable it to resist microbial invasion of its tissues and give it a natural immunity or
innate resistance against many microorganisms. Neisseria gonorrhoeae (small red dots) in pus
from a man with a urethral discharge (Gram
Pathogenic bacteria are specially adapted and endowed with mechanisms for overcoming the normal body
stain)
defences, and can invade parts of the body, such as the blood, where bacteria are not normally found. Some
pathogens invade only the surface epithelium, skin or mucous membrane, but many travel more deeply,
spreading through the tissues and disseminating by the lymphatic and blood streams. In some rare cases a pathogenic microbe can infect an entirely healthy
person, but infection usually occurs only if the body's defence mechanisms are damaged by some local trauma or an underlying debilitating disease, such as
wounding, intoxication, chilling, fatigue, and malnutrition. In many cases, it is important to differentiate infection and colonization, which is when the bacteria
are causing little or no harm.
Caused by Mycobacterium tuberculosis bacteria, one of the diseases with the highest disease burden is tuberculosis,
which killed 1.4 million people in 2019, mostly in sub-Saharan Africa.[4] Pathogenic bacteria contribute to other globally
important diseases, such as pneumonia, which can be caused by bacteria such as Staphylococcus, Streptococcus and
Pseudomonas, and foodborne illnesses, which can be caused by bacteria such as Shigella, Campylobacter, and
Salmonella. Pathogenic bacteria also cause infections such as tetanus, typhoid fever, diphtheria, syphilis, and leprosy.
Pathogenic bacteria are also the cause of high infant mortality rates in developing countries.[5] A GBD study estimated
Global number of deaths (A) and
the global death rates from (33) bacterial pathogens, finding such infections contributed to one in 8 deaths (or ~7.7 YLLs (B), by pathogen and GBD
million deaths), which could make it the second largest cause of death globally in 2019.[6][3] super-region, 2019[3]
Most pathogenic bacteria can be grown in cultures and identified by Gram stain and other methods. Bacteria grown in
this way are often tested to find which antibiotics will be an effective treatment for the infection. For hitherto unknown pathogens, Koch's postulates are the
standard to establish a causative relationship between a microbe and a disease.
Diseases
Each species has specific effect and causes symptoms in people who are infected. Some people who are infected with a
pathogenic bacteria do not have symptoms. Immunocompromised individuals are more susceptible to pathogenic
bacteria.[7]
Pathogenic susceptibility
Some pathogenic bacteria cause disease under certain conditions, such as entry through the skin via a cut, through sexual
activity or through compromised immune function.
Some species of Streptococcus and Staphylococcus are part of the normal skin microbiota and typically reside on healthy
skin or in the nasopharyngeal region. Yet these species can potentially initiate skin infections. Streptococcal infections
Commensals vs pathogenic bacteria
include sepsis, pneumonia, and meningitis.[8] These infections can become serious creating a systemic inflammatory in COPD
response resulting in massive vasodilation, shock, and death.[9]
Other bacteria are opportunistic pathogens and cause disease mainly in people with immunosuppression or cystic
fibrosis. Examples of these opportunistic pathogens include Pseudomonas aeruginosa, Burkholderia cenocepacia, and
Mycobacterium avium.[10][11]
Intracellular
Obligate intracellular parasites (e.g. Chlamydophila, Ehrlichia, Rickettsia) are only able to grow and replicate inside
other cells. Infections due to obligate intracellular bacteria may be asymptomatic, requiring an incubation period. An abscess caused by opportunistic
Examples of obligate intracellular bacteria include Rickettsia prowazekii (typhus) and Rickettsia rickettsii, (Rocky S. aureus bacteria.
Mountain spotted fever).
Chlamydia are intracellular parasites. These pathogens can cause pneumonia or urinary tract infection and may be involved in coronary heart disease.[12]
Other groups of intracellular bacterial pathogens include Salmonella, Neisseria, Brucella, Mycobacterium, Nocardia, Listeria, Francisella, Legionella, and
Yersinia pestis. These can exist intracellularly, but can exist outside host cells.
Bacterial vaginosis is a condition of the vaginal microbiota in which an excessive growth of Gardnerella vaginalis and other mostly anaerobic
bacteria displace the beneficial Lactobacilli species that maintain healthy vaginal microbial populations.[13]
Bacterial meningitis is a bacterial inflammation of the meninges, which are the protective membranes covering the brain and spinal cord.
Bacterial pneumonia is a bacterial infection of the lungs.
Urinary tract infection is predominantly caused by bacteria. Symptoms include the strong and frequent sensation or urge to urinate, pain
during urination, and urine that is cloudy.[14] The most frequent cause is Escherichia coli. Urine is typically sterile but contains a variety of
salts and waste products. Bacteria can ascend into the bladder or kidney and causing cystitis and nephritis.[15][16]
Bacterial gastroenteritis is caused by enteric, pathogenic bacteria. These pathogenic species are usually distinct from the usually harmless
bacteria of the normal gut flora. But a different strain of the same species may be pathogenic. The distinction is sometimes difficult as in the
case of Escherichia.
Bacterial skin infections include:
Impetigo is a highly contagious bacterial skin infection commonly seen in children.[17] It is caused by Staphylococcus aureus, and
Streptococcus pyogenes.[18]
Erysipelas is an acute streptococcus bacterial infection[19] of the deeper skin layers that spreads via with lymphatic system.
Cellulitis is a diffuse inflammation[20] of connective tissue with severe inflammation of dermal and subcutaneous layers of the skin.
Cellulitis can be caused by normal skin flora or by contagious contact, and usually occurs through open skin, cuts, blisters, cracks in the
skin, insect bites, animal bites, burns, surgical wounds, intravenous drug injection, or sites of intravenous catheter insertion. In most cases
it is the skin on the face or lower legs that is affected, though cellulitis can occur in other tissues.
Mechanisms of damage
The symptoms of disease appear as pathogenic bacteria damage host tissues or interfere with their function. The bacteria can damage host cells directly or
indirectly by provoking an immune response that inadvertently damages host cells,[21] or by releasing toxins.[22]
Direct
Once pathogens attach to host cells, they can cause direct damage as the pathogens use the host cell for nutrients and produce waste products.[23] For example,
Streptococcus mutans, a component of dental plaque, metabolizes dietary sugar and produces acid as a waste product. The acid decalcifies the tooth surface to
cause dental caries.[24]
Toxin production
Endotoxins are the lipid portions of lipopolysaccharides that are part of the outer membrane of the cell wall of gram-
negative bacteria. Endotoxins are released when the bacteria lyses, which is why after antibiotic treatment, symptoms
can worsen at first as the bacteria are killed and they release their endotoxins. Exotoxins are secreted into the
surrounding medium or released when the bacteria die and the cell wall breaks apart.[25]
Indirect
An excessive or inappropriate immune response triggered by an infection may damage host cells.[1]
Survival in host
Iron is required for humans, as well as the growth of most bacteria. To obtain free iron, some pathogens secrete proteins
called siderophores, which take the iron away from iron-transport proteins by binding to the iron even more tightly. Once the iron-siderophore complex is
formed, it is taken up by siderophore receptors on the bacterial surface and then that iron is brought into the bacterium.[25]
Bacterial pathogens also require access to carbon and energy sources for growth. To avoid competition with host cells for glucose which is the main energy
source used by human cells, many pathogens including the respiratory pathogen Haemophilus influenzae specialise in using other carbon sources such as lactate
that are abundant in the human body [26]
Identification
Typically identification is done by growing the organism in a wide range of cultures which can take up to 48 hours. The growth is then visually or genomically
identified. The cultured organism is then subjected to various assays to observe reactions to help further identify species and strain.[27]
Treatment
Bacterial infections may be treated with antibiotics, which are classified as bacteriocidal if they kill bacteria or
bacteriostatic if they just prevent bacterial growth. There are many types of antibiotics and each class inhibits a process
that is different in the pathogen from that found in the host. For example, the antibiotics chloramphenicol and tetracyclin
inhibit the bacterial ribosome but not the structurally different eukaryotic ribosome, so they exhibit selective toxicity.[28]
Antibiotics are used both in treating human disease and in intensive farming to promote animal growth. Both uses may
be contributing to the rapid development of antibiotic resistance in bacterial populations.[29] Phage therapy, using
bacteriophages can also be used to treat certain bacterial infections.[30]
Borrelia burgdorferi
Borrelia garinii Negative,
Borrelia[31] Spirochete Anaerobic Extracellular
stains poorly
Borrelia afzelii
Borrelia recurrentis
Brucella abortus
Brucella[31] Brucella canis Negative Coccobacilli Aerobic Intracellular
Brucella melitensis
Brucella suis
Spiral rods[34]
Campylobacter[31] Campylobacter jejuni Negative Microaerophilic[34] Extracellular
coccoid in older cultures[34]
Clostridium botulinum
Clostridium[31] Clostridioides difficile Positive Large, blunt-ended rods Obligate anaerobic Extracellular
Clostridium perfringens
Clostridium tetani
Corynebacterium Positive
Corynebacterium[31] Rods Mostly facultative anaerobic Extracellular
diphtheriae[33][35][36] (unevenly)
Extracellular or
Escherichia[5][33][38] Escherichia coli Negative Rods Facultative anaerobic
Intracellular
Negative,
Legionella[31] Legionella pneumophila Cocobacilli Aerobic Facultative intracellular
stains poorly
Leptospira interrogans
Leptospira santarosai Negative,
Leptospira[33][41] Spirochete Strictly aerobic Extracellular
stains poorly
Leptospira weilii
Leptospira noguchii
Listeria[31] Listeria monocytogenes Positive, darkly Slender, short rods Facultative Anaerobic Facultative intracellular
Mycobacterium leprae
Mycobacterium[31] Mycobacterium (none) Long, slender rods Aerobic Intracellular
tuberculosis
Mycobacterium ulcerans
Gonococcus: facultative
Neisseria gonorrhoeae intracellular
Neisseria[33][42] Negative Kidney bean-shaped Aerobic
N. meningitidis:
Neisseria meningitidis
extracellular
Streptococcus agalactiae
Streptococcus[31] Streptococcus pneumoniae Positive Ovoid to spherical Facultative anaerobic Extracellular
Streptococcus pyogenes
Negative,
Treponema[31] Treponema pallidum stains poorly
Spirochete Aerobic Extracellular
Yersinia pestis
Yersinia enterocolitica Negative,
Yersinia[33][47] Small rods Facultative anaerobe Intracellular
bipolarly
Yersinia
pseudotuberculosis
Overall age-standardised mortality rate per 100 000 Global number of Global number of deaths,
population for 33 pathogens investigated, 2019[3] deaths (A) and YLLs by pathogen, age, and sex
(B), by pathogen groups, 2019[3]
and infectious
syndrome, 2019[3]
This is description of the more common genera and species presented with their clinical characteristics and treatments.
Species of human pathogenic bacteria
Whooping Pertussis
Contact with respiratory Macrolides[33] such as
cough[33][48] vaccine,[33][48] such
Bordetella pertussis droplets expelled by erythromycin,[33][48]
Secondary bacterial before paroxysmal as in DPT
infected human hosts.[33]
pneumonia[33] stage[48] vaccine[33][48]
Lyme disease[56][57]
Wearing clothing that
Early localized: Doxycycline for adults,
B. burgdorferi[33][48] Ixodes hard ticks erythema migrans limits skin exposure to
amoxicillin for children,
Reservoir in mice, other ticks.[33]
B. garinii[33] Early disseminated: ceftriaxone for
small mammals, and neuroborreliosis, Insect repellent.[33]
B. afzelii[33] Lyme carditis neurological
birds[55] Avoid areas where
Late: Lyme arthritis, involvement[56]
ticks are found.[33]
Achrodermatitis
Borrelia chronica (B. afzelii
only)
Good hygiene[33]
Fecal–oral from animals Avoiding
Treat symptoms[33]
(mammals and contaminated
Enteritis,[33] bloody Fluoroquinolone[48]
fowl)[33][48] diarrhea[48] water[33]
Campylobacter jejuni such as
Uncooked meat Guillain–Barré Pasteurizing milk and
ciprofloxacin[33] in
(especially poultry)[33][48] syndrome[48] (muscle milk products[33]
weakness) severe cases[33]
Contaminated water[33] Cooking meat
(especially poultry)[33]
Chlamydia
Respiratory Doxycycline[33][48]
C. pneumoniae droplets[33][48] Atypical pneumonia[48] Erythromycin[33][48] None[33]
Trachoma[33][48]
Neonatal
conjunctivitis[33][48]
Neonatal
vaginal sex[33]
pneumonia[33][48]
oral sex[33]
Nongonococcal Erythromycin[33][48] Erythromycin or silver
anal sex[33] Vertical from
urethritis (NGU)[33][48] (adults)[48] nitrate in newborn's
mother to
C. trachomatis Urethritis[33][48] Doxycycline[33][48] eyes[33]
newborn(ICN)[33]
Pelvic inflammatory (infants and pregnant Safe sex[33]
Direct or contaminated
disease[33][48] women)[48] Abstinence[33]
surfaces and flies
Epididymitis[33][48]
(trachoma)[33]
Prostatitis[33][48]
Lymphogranuloma
venereum
(LGV)[33][48]
Tetracycline[33]
Inhalation of dust with
Chlamydophila psittaci secretions or feces from
Psittacosis, mainly Doxycycline[33] -
atypical pneumonia
birds (e.g. parrots) Erythromycin[33]
Antitoxin[33][48]
Botulism: Mainly Penicillin[48] Proper food
Spores from soil,[33][48]
C. botulinum persevere in canned food, muscle weakness and Hyperbaric oxygen[48] preservation
smoked fish and honey[48] paralysis[48] Mechanical techniques
ventilation[48]
Discontinuing
responsible
Gut flora,[33][48]
Pseudomembranous antibiotic[33][48]
C. difficile overgrowing when other Fecal bacteriotherapy
colitis[33][48] Vancomycin or
flora is depleted[33]
metronidazole if
severe[33][48]
Gas gangrene:
Debridement or
amputation[33][48]
Hyperbaric
Clostridium Anaerobic
medicine[33][48]
Spores in soil[33][48] cellulitis[33][48] High doses of
Vaginal flora and gut Gas gangrene[33][48] Appropriate food
C. perfringens doxycycline[33] or handling[33]
flora[33] Acute food
penicillin G[33][48] and
poisoning[33][48]
clindamycin[48]
Food poisoning:
Supportive care is
sufficient[33]
Tetanus immune
globulin[33][48]
Sedatives[33]
Spores in soil, skin Tetanus vaccine (such
Tetanus: muscle Muscle relaxants[33]
C. tetani penetration through as in the DPT
spasms[60] Mechanical
wounds[33][48] vaccine)[33]
ventilation[33][48]
Penicillin or
metronidazole[48]
Diphtheria: Fever,
Horse serum antitoxin
respiratory droplets sore throat and neck
Corynebacterium diphtheriae Erythromycin DPT vaccine
part of human flora swelling, potentially
Penicillin
narrowing airways.[61]
E. canis[48] Ehrlichiosis:[48]
Dog tick[48] doxycycline[48]
Ehrlichia E. chaffeensis[48] headache, muscle
aches, and fatigue rifampin[48]
Bacterial
Part of gut flora,[48] Ampicillin (combined No vaccine Hand
E. faecalis endocarditis,[48] biliary
opportunistic or entering with aminoglycoside in washing and other
Enterococcus tract infections,[48]
E. faecium through GI tract or urinary endocarditis)[48] nosocomial
urinary tract
system wounds[33] Vancomycin[33] prevention
infections[48]
Diarrhea[33][48]
Urinary tract
Gut flora,[33][48] and in infections (UTI)[33][48]
urinary tract[48]
Meningitis in UTI:[33]
E. coli (generally) Spreading infants[33][48]
extraintestinally or (resistance-tests are
proliferating in the GI Hospital-acquired required first)
tract[33] pneumonia[48]
Hospital-acquired Co-trimoxazole
sepsis[48]
Fluoroquinolone, e.g.
ciprofloxacin (no vaccine or
[48] preventive drug)[33]
Fecal–oral through Meningitis:[33]
Enterotoxigenic E. coli food and water[33] Traveller's Cooking ground beef
Escherichia (ETEC) Direct physical diarrhea[33][48] and pasteurizing milk
Cephalosporin (e.g.
contact[33] cefotaxime) and against O157:H7[33]
gentamicin Hand washing and
combination disinfection[33]
Enteropathogenic E. coli Vertical, in utero or at
Diarrhea in infants[33]
birth[33] Diarrhea:[33]
Meningitis:[33]
(resistance-tests are
Bacterial
meningitis[33][48] required first)
Upper respiratory Hib vaccine to
Droplet contact[33] Third generation
Haemophilus influenzae tract infections[33][48] infants[33][48]
Human flora of e.g. cephalosporin, e.g.
Pneumonia,[33][48] cefotaxime or Rifampin
upper respiratory tract[33]
bronchitis[33] ceftriaxone[33] prophylactically[33]
Septic arthritis in Ampicillin and
infants[48] sulbactam
combination[33]
Peptic ulcer[33][48]
Colonizing stomach[33] Chronic gastritis[48] Tetracycline,
metronidazole and (No vaccine or
Helicobacter pylori Risk factor for gastric
Unclear person-to- bismuth salt preventive drug)[33]
person transmission[33] carcinoma and
gastric B-cell combination[33]
lymphoma[33]
Klebsiella
pneumonia, with
Mouth, skin, and gut significant lung
3rd generation
Klebsiella pneumoniae flora.[64] necrosis and
cephalosporin[48]
hemoptysis[48] hand hygiene.[65]
Pneumonia upon
aspiration Hospital-acquired ciprofloxacin[48]
urinary tract infection
and sepsis[48]
Tuberculoid form:
Leprosy (Hansen's
Prolonged human- Dapsone and
disease):[33]
human contact, e.g.
granulomas of the rifampin[33] BCG vaccine shows
M. leprae through exudates from
skin lesions to abrasion nerves, respiratory Lepromatous form: some effects[33]
tract, skin, and
of other person[33]
eyes.[69]
Clofazimine[33]
(difficult, see
Tuberculosis treatment
for more details)[33]
Standard "short"
Mycobacterium
course:[33]
Human flora[33][48]
Mycoplasma pneumoniae Mycoplasma Doxycycline and
Respiratory pneumonia[33] erythromycin[33][48]
droplets[33][48]
Uncomplicated
gonorrhea:[33]
Gonorrhea[33][48] Ceftriaxone[48]
Tetracycline, e.g.
Urethritis doxycycline if also
chlamydia is (No vaccine)[33]
(men)[48]
suspected[48]
Sexually Pelvic Safe sex[33]
inflammatory Spectinomycin for
N. gonorrhoeae transmitted[33][48]
disease resistance[33][48] or Erythromycin into
vertical in birth[33] (women)[48] patient allergy to eyes of newborn at
cephalosporin[33] risk[33][48]
Ophthalmia Ophthalmia
Neisseria
neonatorum[33][48]
neonatorum:
[33][48]
Septic arthritis
Erythromycin[33][48] +
ceftriaxone[48]
Meningococcal
disease including
meningitis[33][48] NmVac4-A/C/Y/W-
Penicillin G[33][48]
N. meningitidis Droplet transmission[33] Sepsis, including 135 vaccine[33][48]
[33][48]
Ceftriaxone
Waterhouse- Rifampin[33][48]
Friderichsen
syndrome[33][48]
Nocardiosis:[48]
Pneumonia,
endocarditis, keratitis,
Nocardia asteroides In soil[48] TMP/SMX[48]
neurological or
lymphocutaneous
infection
(no preventive drug or
approved vaccine)[33]
Coagulase-positive
staphylococcal
infections:
Skin infections,
including
impetigo[33][48]
Acute infective
endocarditis[33][48] Incision and drainage
Septis[33] of localized lesions[33] (no vaccine or
Necrotizing preventive drug)
Human flora on mucosae Nafcillin,[33][48]
aureus in e.g. anterior nares, pneumonia[33] oxacillin,[33] Barrier precautions,
skin and vagina,[33][48] Meningitis[48] methicillin[48] washing hands and
entering through wound fomite disinfection in
Osteomyelitis[48] Vancomycin for
Methicillin-resistant hospitals
Toxinoses
(MRSA)[33]
Staphylococcus Scalded skin
syndrome[33][48]
Toxic shock
syndrome[33][48]
Staphylococcal
food
poisoning[33][48]
Infections of
Human flora in skin,[33][48] implanted prostheses
epidermidis anterior nares[33] and (e.g. heart valves[33] Vancomycin[33][48] None[33]
mucous membranes[48] and joints[48]) and
catheters[33][48]
Acute bacterial
pneumonia & 23-serotype vaccine
Respiratory droplets meningitis in for adults
Human flora in adults[33][48] (PPV)[33][48]
pneumoniae Penicillin G[33][48]
nasopharynx[48] Otitis media and Heptavalent
(spreading in sinusitis in conjugated vaccine
immunocompromised)[33] children[33][48] for children (PCV)[33]
Sepsis[48]
Streptococcus
Streptococcal
pharyngitis[33][48]
Sepsis[48] Penicillin G[33][48] or
Scarlet fever[33][48] V[48]
No vaccine[33]
Rheumatic Macrolide, e.g.
Respiratory droplets[33] fever[33][48] clarithromycin[33] or Rapid antibiotic
pyogenes Direct physical contact Impetigo and erythromycin[48] in treatment helps
with impetigo lesions[33] erysipelas[33][48] penicillin allergy prevent rheumatic
fever[33]
Puerperal fever[33] Drainage and
Necrotizing debridement for
fasciitis[33] necrotizing fasciitis[33]
Poststreptococcal
glomerulonephritis[48]
Subacute bacterial
endocarditis[48]
Oral flora,[48] penetration
viridans Dental cavities[48] Penicillin G[48]
through abrasions
Abscesses of brain
and liver[48]
Fluid[48] and
Fecal–oral route[48] electrolyte
Proper sanitation[33]
Vibrio cholerae Cholera: Severe "rice
Contaminated water and water" diarrhea[48] replacement[33] Adequate food
raw seafood[33] preparation[33]
Doxycycline[33][48]
Streptomycin
Fleas from animals[33][76] Plague:
primarily[33][77][78] Plague vaccine[80]
Yersinia pestis Ingestion of animal Bubonic plague Tetracyclin[33][79] Minimize exposure to
tissues[33]
Pneumonic plague Supportive therapy for rodents and fleas[33]
Respiratory droplets[33]
shock[33]
Genetic transformation
Of the 59 species listed in the table with their clinical characteristics, 11 species (or 19%) are known to be capable of natural genetic transformation.[81] Natural
transformation is a bacterial adaptation for transferring DNA from one cell to another. This process includes the uptake of exogenous DNA from a donor cell by
a recipient cell and its incorporation into the recipient cell's genome by recombination. Transformation appears to be an adaptation for repairing damage in the
recipient cell's DNA. Among pathogenic bacteria, transformation capability likely serves as an adaptation that facilitates survival and infectivity.[81] The
pathogenic bacteria able to carry out natural genetic transformation (of those listed in the table) are Campylobacter jejuni, Enterococcus faecalis, Haemophilus
influenzae, Helicobacter pylori, Klebsiella pneumoniae, Legionella pneumophila, Neisseria gonorrhoeae, Neisseria meningitidis, Staphylococcus aureus,
Streptococcus pneumoniae and Vibrio cholerae.
See also
Human microbiome project
List of antibiotics
Pathogenic viruses
Notes
1. Relapsing fever can also be caused by the following Borrelia species: B. crocidurae, B. duttonii, B. hermsii, B. hispanica, B. miyamotoi, B.
persica, B. turicatae and B. venezuelensis.
- Barbour, Alan G. (2017). "Relapsing Fever". In Kasper, Dennis L.; Fauci, Anthony S. (eds.). Harrison's Infectious Diseases (3rd ed.). New
York: McGraw Hill Education. pp. 678–687. ISBN 978-1-259-83597-1.
References
1. Ryan, Kenneth J.; Ray, C. George; Ahmad, Nafees; Drew, W. 9. Fish DN (February 2002). "Optimal antimicrobial therapy for sepsis"
Lawrence; Lagunoff, Michael; Pottinger, Paul; Reller, L. Barth; (http://www.ajhp.org/cgi/pmidlookup?view=long&pmid=11885408).
Sterling, Charles R. (2014). "Pathogenesis of Bacterial Infections". Am J Health Syst Pharm. 59 (Suppl 1): S13–9.
Sherris Medical Microbiology (6th ed.). New York: McGraw Hill doi:10.1093/ajhp/59.suppl_1.S13 (https://doi.org/10.1093%2Fajhp%
Education. pp. 391–406. ISBN 978-0-07-181826-1. 2F59.suppl_1.S13). PMID 11885408 (https://pubmed.ncbi.nlm.nih.g
2. McFall-Ngai, Margaret (2007-01-11). "Adaptive Immunity: Care for ov/11885408).
the community" (https://doi.org/10.1038%2F445153a). Nature. 445 10. Heise E (1982). "Diseases associated with immunosuppression" (ht
(7124): 153. Bibcode:2007Natur.445..153M (https://ui.adsabs.harva tps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1568899). Environ
rd.edu/abs/2007Natur.445..153M). doi:10.1038/445153a (https://do Health Perspect. 43: 9–19. doi:10.2307/3429162 (https://doi.org/10.
i.org/10.1038%2F445153a). ISSN 0028-0836 (https://search.worldc 2307%2F3429162). JSTOR 3429162 (https://www.jstor.org/stable/3
at.org/issn/0028-0836). PMID 17215830 (https://pubmed.ncbi.nlm.n 429162). PMC 1568899 (https://www.ncbi.nlm.nih.gov/pmc/articles/
ih.gov/17215830). S2CID 9273396 (https://api.semanticscholar.org/ PMC1568899). PMID 7037390 (https://pubmed.ncbi.nlm.nih.gov/70
CorpusID:9273396). 37390).
3. Ikuta, Kevin S.; Swetschinski, Lucien R.; Aguilar, Gisela Robles; 11. Saiman L (2004). "Microbiology of early CF lung disease". Paediatr
Sharara, Fablina; Mestrovic, Tomislav; Gray, Authia P.; Weaver, Respir Rev. 5 (Suppl A): S367–9. doi:10.1016/S1526-
Nicole Davis; Wool, Eve E.; et al. (21 November 2022). "Global 0542(04)90065-6 (https://doi.org/10.1016%2FS1526-0542%2804%
mortality associated with 33 bacterial pathogens in 2019: a 2990065-6). PMID 14980298 (https://pubmed.ncbi.nlm.nih.gov/149
systematic analysis for the Global Burden of Disease Study 2019" 80298).
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763654). The 12. Belland R, Ouellette S, Gieffers J, Byrne G (2004). "Chlamydia
Lancet. 400 (10369): 2221–2248. doi:10.1016/S0140- pneumoniae and atherosclerosis" (https://doi.org/10.1046%2Fj.146
6736(22)02185-7 (https://doi.org/10.1016%2FS0140-6736%2822% 2-5822.2003.00352.x). Cell Microbiol. 6 (2): 117–27.
2902185-7). ISSN 0140-6736 (https://search.worldcat.org/issn/0140 doi:10.1046/j.1462-5822.2003.00352.x (https://doi.org/10.1046%2F
-6736). PMC 9763654 (https://www.ncbi.nlm.nih.gov/pmc/articles/P j.1462-5822.2003.00352.x). PMID 14706098 (https://pubmed.ncbi.n
MC9763654). PMID 36423648 (https://pubmed.ncbi.nlm.nih.gov/36 lm.nih.gov/14706098). S2CID 45218449 (https://api.semanticschola
423648). r.org/CorpusID:45218449).
4. "Tuberculosis (TB)" (https://www.who.int/en/news-room/fact-sheets/ 13. Muzny CA, Schwebke JR (August 2016). "Pathogenesis of
detail/tuberculosis). www.who.int. Bacterial Vaginosis: Discussion of Current Hypotheses" (https://ww
5. Santosham, Mathuram; Chan, Grace J.; Lee, Anne CC; Baqui, w.ncbi.nlm.nih.gov/pmc/articles/PMC4957507). The Journal of
Abdullah H.; Tan, Jingwen; Black, Robert E. (2013). "Risk of Early- Infectious Diseases. 214 (Suppl 1): S1–5. doi:10.1093/infdis/jiw121
Onset Neonatal Infection with Maternal Infection or Colonization: A (https://doi.org/10.1093%2Finfdis%2Fjiw121). PMC 4957507 (http
Global Systematic Review and Meta-Analysis" (https://www.ncbi.nl s://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957507).
m.nih.gov/pmc/articles/PMC3747995). PLOS Medicine. 10 (8): PMID 27449868 (https://pubmed.ncbi.nlm.nih.gov/27449868).
e1001502. doi:10.1371/journal.pmed.1001502 (https://doi.org/10.13 14. "Urinary Tract Infections" (http://www.medicinenet.com/urine_infecti
71%2Fjournal.pmed.1001502). ISSN 1549-1676 (https://search.wor on/page4.htm). Retrieved 2010-02-04.
ldcat.org/issn/1549-1676). PMC 3747995 (https://www.ncbi.nlm.nih.
15. Roxe DM. Urinalysis. In: Walker HK, Hall WD, Hurst JW, editors.
gov/pmc/articles/PMC3747995). PMID 23976885 (https://pubmed.n Clinical Methods: The History, Physical, and Laboratory
cbi.nlm.nih.gov/23976885).
Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter
6. Hou, Chia-Yi (23 November 2022). "Bacterial infections linked to 1 191. Available from: https://www.ncbi.nlm.nih.gov/books/NBK302/
in 8 deaths in 2019" (https://thehill.com/changing-america/well-bein
16. Hollyer I, Ison MG (April 2018). "The challenge of urinary tract
g/prevention-cures/3748033-bacterial-infections-linked-to-1-in-8-de
infections in renal transplant recipients" (https://doi.org/10.1111%2F
aths-in-2019/). The Hill. Retrieved 12 December 2022.
tid.12828). Transplant Infectious Disease. 20 (2): e12828.
7. Azoulay E, Russell L, Van de Louw A, Metaxa V, Bauer P, Povoa P, doi:10.1111/tid.12828 (https://doi.org/10.1111%2Ftid.12828).
Montero JG, Loeches IM, Mehta S, Puxty K, Schellongowski P, PMID 29272071 (https://pubmed.ncbi.nlm.nih.gov/29272071).
Rello J, Mokart D, Lemiale V, Mirouse A (February 2020). S2CID 4724463 (https://api.semanticscholar.org/CorpusID:472446
"Diagnosis of severe respiratory infections in immunocompromised 3).
patients" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080052).
17. "Impetigo" (http://www.nhs.uk/conditions/Impetigo/Pages/Introductio
Intensive Care Medicine. 46 (2): 298–314. doi:10.1007/s00134-019- n.aspx). National Health Service. 19 October 2017. Page last
05906-5 (https://doi.org/10.1007%2Fs00134-019-05906-5).
reviewed: 17/07/2014
PMC 7080052 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080
052). PMID 32034433 (https://pubmed.ncbi.nlm.nih.gov/32034433). 18. Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; & Mitchell, Richard
N. (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier.
8. "Streptococcal Infections - Infectious Diseases" (https://www.msdm pp. 843 ISBN 978-1-4160-2973-1
anuals.com/professional/infectious-diseases/gram-positive-cocci/str
eptococcal-infections). MSD Manual Professional Edition. Retrieved 19. "erysipelas" (https://web.archive.org/web/20090628224336/http://w
2 May 2021. ww.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppd
ocs/us/common/dorlands/dorland/three/000036667.htm) at
Dorland's Medical Dictionary
20. "cellulitis" (https://web.archive.org/web/20090628224336/http://ww 33. Fisher, Bruce; Harvey, Richard P.; Champe, Pamela C. (2007).
w.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdo Lippincott's Illustrated Reviews: Microbiology (Lippincott's Illustrated
cs/us/common/dorlands/dorland/two/000019077.htm) at Dorland's Reviews Series). Hagerstown, MD: Lippincott Williams & Wilkins.
Medical Dictionary pp. 332–353. ISBN 978-0-7817-8215-9.
21. Greenwood, David; Barer, Mike; Slack, Richard; Irving, Will (2012). 34. Epps SV, Harvey RB, Hume ME, Phillips TD, Anderson RC, Nisbet
"Bacterial Pathogenicity". Medical Microbiology, a Guide to DJ (2013). "Foodborne Campylobacter: infections, metabolism,
Microbial Infections: Pathogenesis, Immunity, Laboratory pathogenesis and reservoirs" (https://www.ncbi.nlm.nih.gov/pmc/arti
Investigation, and Control (18th ed.). Edinburgh: Churchill cles/PMC3881114). International Journal of Environmental
Livingstone. pp. 156–167. ISBN 9780702040894. Research and Public Health. 10 (12): 6292–304.
22. Rudkin JK, McLoughlin RM, Preston A, Massey RC (September doi:10.3390/ijerph10126292 (https://doi.org/10.3390%2Fijerph1012
2017). "Bacterial toxins: Offensive, defensive, or something else 6292). PMC 3881114 (https://www.ncbi.nlm.nih.gov/pmc/articles/P
altogether?" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC56083 MC3881114). PMID 24287853 (https://pubmed.ncbi.nlm.nih.gov/24
99). PLOS Pathogens. 13 (9): e1006452. 287853).
doi:10.1371/journal.ppat.1006452 (https://doi.org/10.1371%2Fjourn 35. Bowden GHW (1996). Baron S; et al. (eds.). Actinomycosis in:
al.ppat.1006452). PMC 5608399 (https://www.ncbi.nlm.nih.gov/pm Baron's Medical Microbiology (4th ed.). Univ of Texas Medical
c/articles/PMC5608399). PMID 28934339 (https://pubmed.ncbi.nlm. Branch. ISBN 978-0-9631172-1-2. (via NCBI Bookshelf) (https://ww
nih.gov/28934339). w.ncbi.nlm.nih.gov/books/bv.fcgi?rid=mmed.section.1883).
23. Tortora, Gerald J.; Funke, Berdell R.; Case, Christine L. (2016). 36. Baron, Samuel (1996). Medical Microbiology (4th ed.). University of
"Microbial Mechanisms of Pathogenicity". Microbiology, an Texas Medical Branch at Galveston, Galveston, Texas. ISBN 978-0-
Introduction (12th ed.). Pearson Education. pp. 417–438. 9631172-1-2.
ISBN 978-0-321-92915-0. 37. Rollins, David M. (2000). "BSCI424 Laboratory Media" (http://www.li
24. Nash, Anthony A.; Dalziel, Robert G.; Fitzgerald, J. Ross (2015). fe.umd.edu/classroom/bsci424/LabMaterialsMethods/BSCI424Medi
"Mechanisms of Cell and Tissue Damage". Mims' Pathogenesis of a.htm). University of Maryland. Retrieved 2008-11-18.
Infectious Disease (6th ed.). London: Academic Press. pp. 171– 38. Cain, Donna (January 14, 2015). "MacConkey Agar (CCCCD
231. ISBN 978-0-12-397188-3. Microbiology" (https://web.archive.org/web/20150426154407/http://i
25. Tortota, Gerard (2013). Microbiology an Introduction. Pearson. ws2.collin.edu/dcain/CCCCD%20Micro/macconkeyagar.htm). Collin
ISBN 978-0-321-73360-3. College. Archived from the original (http://iws2.collin.edu/dcain/CCC
26. Hosmer, Jennifer; Nasreen, Marufa; Dhouib, Rabeb; Essilfie, Ama- CD%20Micro/macconkeyagar.htm) on April 26, 2015. Retrieved
Tawiah; Schirra, Horst Joachim; Henningham, Anna; Fantino, May 3, 2015.
Emmanuelle; Sly, Peter; McEwan, Alastair G.; Kappler, Ulrike 39. Gunn BA (1984). "Chocolate agar, a differential medium for gram-
(2022-01-27). "Access to highly specialized growth substrates and positive cocci" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714
production of epithelial immunomodulatory metabolites determine 42). Journal of Clinical Microbiology. 20 (4): 822–3.
survival of Haemophilus influenzae in human airway epithelial cells" doi:10.1128/JCM.20.4.822-823.1984 (https://doi.org/10.1128%2FJ
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794153). PLOS CM.20.4.822-823.1984). PMC 271442 (https://www.ncbi.nlm.nih.go
Pathogens. 18 (1): e1010209. doi:10.1371/journal.ppat.1010209 (ht v/pmc/articles/PMC271442). PMID 6490866 (https://pubmed.ncbi.nl
tps://doi.org/10.1371%2Fjournal.ppat.1010209). ISSN 1553-7374 (h m.nih.gov/6490866).
ttps://search.worldcat.org/issn/1553-7374). PMC 8794153 (https://w 40. Stevenson TH, Castillo A, Lucia LM, Acuff GR (2000). "Growth of
ww.ncbi.nlm.nih.gov/pmc/articles/PMC8794153). PMID 35085362 Helicobacter pylori in various liquid and plating media" (https://doi.o
(https://pubmed.ncbi.nlm.nih.gov/35085362). rg/10.1046%2Fj.1472-765x.2000.00699.x). Lett. Appl. Microbiol. 30
27. Cassells AC (2012). "Pathogen and Biological Contamination (3): 192–6. doi:10.1046/j.1472-765x.2000.00699.x (https://doi.org/1
Management in Plant Tissue Culture: Phytopathogens, Vitro 0.1046%2Fj.1472-765x.2000.00699.x). PMID 10747249 (https://pu
Pathogens, and Vitro Pests". Plant Cell Culture Protocols. Methods bmed.ncbi.nlm.nih.gov/10747249). S2CID 24668819 (https://api.se
in Molecular Biology. Vol. 877. pp. 57–80. doi:10.1007/978-1- manticscholar.org/CorpusID:24668819).
61779-818-4_6 (https://doi.org/10.1007%2F978-1-61779-818-4_6). 41. Johnson RC, Harris VG (1967). "Differentiation of Pathogenic and
ISBN 978-1-61779-817-7. PMID 22610620 (https://pubmed.ncbi.nl Saprophytic Leptospires I. Growth at Low Temperatures" (https://w
m.nih.gov/22610620). ww.ncbi.nlm.nih.gov/pmc/articles/PMC251866). J. Bacteriol. 94 (1):
28. Yonath A, Bashan A (2004). "Ribosomal crystallography: initiation, 27–31. doi:10.1128/JB.94.1.27-31.1967 (https://doi.org/10.1128%2
peptide bond formation, and amino acid polymerization are FJB.94.1.27-31.1967). PMC 251866 (https://www.ncbi.nlm.nih.gov/
hampered by antibiotics" (https://doi.org/10.1146%2Fannurev.micr pmc/articles/PMC251866). PMID 6027998 (https://pubmed.ncbi.nl
o.58.030603.123822). Annu Rev Microbiol. 58: 233–51. m.nih.gov/6027998).
doi:10.1146/annurev.micro.58.030603.123822 (https://doi.org/10.11 42. "Thayer Martin Agar (Modified) Procedure" (http://webmedia.unmc.
46%2Fannurev.micro.58.030603.123822). PMID 15487937 (https:// edu/alliedhealth/CLS/CLS418%2008/Thayer%20Martin%20Agar%2
pubmed.ncbi.nlm.nih.gov/15487937). 0Procedure%2008.pdf) (PDF). University of Nebraska-Medical
29. Khachatourians GG (November 1998). "Agricultural use of Center, Clinical Laboratory Science Program. Retrieved
antibiotics and the evolution and transfer of antibiotic-resistant 2015-05-03.
bacteria" (http://www.cmaj.ca/cgi/pmidlookup?view=reprint&pmid=9 43. Allen, Mary E. (2005). "MacConkey Agar Plates Protocols" (https://
835883). CMAJ. 159 (9): 1129–36. PMC 1229782 (https://www.ncb web.archive.org/web/20150507033028/http://www.microbelibrary.or
i.nlm.nih.gov/pmc/articles/PMC1229782). PMID 9835883 (https://pu g/component/resource/laboratory-test/2855-macconkey-agar-plates
bmed.ncbi.nlm.nih.gov/9835883). -protocols). American Society for Microbiology. Archived from the
30. Keen, E. C. (2012). "Phage Therapy: Concept to Cure" (https://ww original (http://www.microbelibrary.org/component/resource/laborato
w.ncbi.nlm.nih.gov/pmc/articles/PMC3400130). Frontiers in ry-test/2855-macconkey-agar-plates-protocols) on 2015-05-07.
Microbiology. 3: 238. doi:10.3389/fmicb.2012.00238 (https://doi.org/ Created: 30 September 2005. Last update: 01 April 2013
10.3389%2Ffmicb.2012.00238). PMC 3400130 (https://www.ncbi.nl 44. "Hektoen Enteric Agar" (http://www.austincc.edu/microbugz/hektoen
m.nih.gov/pmc/articles/PMC3400130). PMID 22833738 (https://pub _enteric_agar.php). Austin Community College District. Retrieved
med.ncbi.nlm.nih.gov/22833738). 2015-05-03.
31. Unless else specified in boxes then ref is: Fisher, Bruce; Harvey, 45. Cassell GH, Waites KB, Crouse DT, Rudd PT, Canupp KC, Stagno
Richard P.; Champe, Pamela C. (2007). Lippincott's Illustrated S, Cutter GR (1988). "Association of Ureaplasma urealyticum
Reviews: Microbiology (Lippincott's Illustrated Reviews Series). infection of the lower respiratory tract with chronic lung disease and
Hagerstown, MD: Lippincott Williams & Wilkins. pp. 332–353. death in very-low-birth-weight infants". Lancet. 2 (8605): 240–5.
ISBN 978-0-7817-8215-9. doi:10.1016/s0140-6736(88)92536-6 (https://doi.org/10.1016%2Fs0
32. Kurzynski TA, Boehm DM, Rott-Petri JA, Schell RF, Allison PE 140-6736%2888%2992536-6). PMID 2899235 (https://pubmed.ncb
(1988). "Comparison of modified Bordet-Gengou and modified i.nlm.nih.gov/2899235). S2CID 6685738 (https://api.semanticschola
Regan-Lowe media for the isolation of Bordetella pertussis and r.org/CorpusID:6685738).
Bordetella parapertussis" (https://www.ncbi.nlm.nih.gov/pmc/article
s/PMC266968). J. Clin. Microbiol. 26 (12): 2661–3.
doi:10.1128/JCM.26.12.2661-2663.1988 (https://doi.org/10.1128%2
FJCM.26.12.2661-2663.1988). PMC 266968 (https://www.ncbi.nlm.
nih.gov/pmc/articles/PMC266968). PMID 2906642 (https://pubmed.
ncbi.nlm.nih.gov/2906642).
46. Pfeffer, C.; Oliver, J.D. (2003). "A comparison of thiosulphate- 62. "ESCHERICHIA COLI" (http://www.phac-aspc.gc.ca/lab-bio/res/psd
citrate-bile salts-sucrose (TCBS) agar and thiosulphate-chloride- s-ftss/escherichia-coli-eng.php). Public Health Agency of Canada.
iodide (TCI) agar for the isolation of Vibrio species from estuarine 2012-04-30. Retrieved 2015-06-02.
environments" (https://doi.org/10.1046%2Fj.1472-765X.2003.0128 63. "Signs & Symptoms" (https://www.cdc.gov/tularemia/signssymptom
0.x). Letters in Applied Microbiology. 36 (3): 150–151. s/). Centers for Disease Control and Prevention. 13 December
doi:10.1046/j.1472-765X.2003.01280.x (https://doi.org/10.1046%2F 2018. Page last reviewed: October 26, 2015
j.1472-765X.2003.01280.x). PMID 12581373 (https://pubmed.ncbi.n
64. Ryan, KJ; Ray, CG, eds. (2004). Sherris Medical Microbiology
lm.nih.gov/12581373). S2CID 34004290 (https://api.semanticschola
(4th ed.). McGraw Hill. ISBN 978-0-8385-8529-0.
r.org/CorpusID:34004290).
65. "Klebsiella pneumoniae in Healthcare Settings" (https://www.cdc.go
47. "Yersinia pestis" (http://www.health.ny.gov/guidance/oph/wadswort v/HAI/organisms/klebsiella/klebsiella.html). Centers for Disease
h/yersinia_pestis.pdf) (PDF). Wadsworth Center. 2006.
Control and Prevention. 19 February 2021. Page last reviewed:
48. "Bacteria Table" (https://web.archive.org/web/20150501071840/htt November 24, 2010. Page last updated: August 27, 2012
p://medschool.creighton.edu/fileadmin/user/medicine/MMI/Files/Bac
66. Slack, A (Jul 2010). "Leptospirosis". Australian Family Physician. 39
teria_Table.pdf) (PDF). Creighton University School of Medicine.
(7): 495–8. PMID 20628664 (https://pubmed.ncbi.nlm.nih.gov/2062
Archived from the original (http://medschool.creighton.edu/fileadmi
8664).
n/user/medicine/MMI/Files/Bacteria_Table.pdf) (PDF) on 2015-05-
01. Retrieved 2015-05-03. 67. McBride, AJ; Athanazio, DA; Reis, MG; Ko, AI (Oct 2005).
"Leptospirosis". Current Opinion in Infectious Diseases. 18 (5):
49. Brook, I (Oct 2008). "Actinomycosis: diagnosis and management".
376–86. doi:10.1097/01.qco.0000178824.05715.2c (https://doi.org/
Southern Medical Journal. 101 (10): 1019–23.
10.1097%2F01.qco.0000178824.05715.2c). PMID 16148523 (http
doi:10.1097/SMJ.0b013e3181864c1f (https://doi.org/10.1097%2FS
s://pubmed.ncbi.nlm.nih.gov/16148523). S2CID 220576544 (https://
MJ.0b013e3181864c1f). PMID 18791528 (https://pubmed.ncbi.nlm.
api.semanticscholar.org/CorpusID:220576544).
nih.gov/18791528). S2CID 19554893 (https://api.semanticscholar.o
rg/CorpusID:19554893). 68. Hartskeerl, Rudy A.; Wagenaar, Jiri F.P. (2017). "Leptospirosis". In
Kasper, Dennis L.; Fauci, Anthony S. (eds.). Harrison's Infectious
50. Mabeza, GF; Macfarlane J (March 2003). "Pulmonary
Diseases. New York: McGraw Hill Education. pp. 672–678.
actinomycosis" (https://doi.org/10.1183%2F09031936.03.0008910 ISBN 978-1-259-83597-1.
3). European Respiratory Journal. 21 (3): 545–551.
doi:10.1183/09031936.03.00089103 (https://doi.org/10.1183%2F09 69. "Leprosy Fact sheet N°101" (https://www.who.int/mediacentre/facts
031936.03.00089103). PMID 12662015 (https://pubmed.ncbi.nlm.ni heets/fs101/en/). World Health Organization. January 2014.
h.gov/12662015). Archived (https://web.archive.org/web/20131212084309/http://www.
who.int/mediacentre/factsheets/fs101/en/) from the original on
51. "Anthrax in animals" (http://www.fao.org/ag/magazine/0112sp.htm).
2013-12-12.
Food and Agriculture Organization. 2001.
70. "Tuberculosis Fact sheet N°104" (https://www.who.int/mediacentre/f
52. "CDC Anthrax Q & A: Treatment" (https://web.archive.org/web/2011 actsheets/fs104/en/). WHO. October 2015. Archived (https://web.ar
0505191339/http://emergency.cdc.gov/agent/anthrax/faq/treatment.
chive.org/web/20120823143802/http://www.who.int/mediacentre/fac
asp). Archived from the original (https://emergency.cdc.gov/agent/a
tsheets/fs104/en/) from the original on 23 August 2012. Retrieved
nthrax/faq/treatment.asp) on 5 May 2011. Retrieved 4 April 2011.
11 February 2016.
53. "FDA approves raxibacumab to treat inhalational anthrax" (https://w 71. Institut Pasteur Press Office - Vaccine against shigellosis (bacillary
ww.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm332
dysentery):a promising clinical trial (http://www.pasteur.fr/ip/easysit
341.htm). Food and Drug Administration. Retrieved 14 December
e/go/03b-00002u-06f/press/press-releases/2009/vaccine-against-sh
2012.
igellosis-bacillary-dysentery-a-promising-clinical-trial) Archived (http
54. Itzhak Brook (Jan 28, 2014). "Bacteroides Infection Follow-up" (htt s://web.archive.org/web/20090225214950/http://www.pasteur.fr/ip/e
p://emedicine.medscape.com/article/233339-followup). Medscape. asysite/go/03b-00002u-06f/press/press-releases/2009/vaccine-agai
Retrieved 2015-09-25. nst-shigellosis-bacillary-dysentery-a-promising-clinical-trial) 2009-
55. Shapiro ED (2014). "Clinical practice. Lyme disease" (https://www.n 02-25 at the Wayback Machine 15 January 2009. Retrieved on 27
cbi.nlm.nih.gov/pmc/articles/PMC4487875). The New England February 2009
Journal of Medicine. 370 (18): 1724–31. 72. Levinson, W. (2010). Review of Medical Microbiology and
doi:10.1056/NEJMcp1314325 (https://doi.org/10.1056%2FNEJMcp Immunology (11th ed.). pp. 94–9.
1314325). PMC 4487875 (https://www.ncbi.nlm.nih.gov/pmc/article 73. "Syphilis - CDC Fact Sheet (Detailed)" (https://www.cdc.gov/std/syp
s/PMC4487875). PMID 24785207 (https://pubmed.ncbi.nlm.nih.gov/
hilis/stdfact-syphilis-detailed.htm). CDC. 2 November 2015.
24785207).
Archived (https://web.archive.org/web/20160206003059/http://www.
56. Sanchez JL (2015). "Clinical Manifestations and Treatment of Lyme cdc.gov/std/syphilis/stdfact-syphilis-detailed.htm) from the original
Disease". Clinics in Laboratory Medicine. 35 (4): 765–78. on 6 February 2016. Retrieved 3 February 2016.
doi:10.1016/j.cll.2015.08.004 (https://doi.org/10.1016%2Fj.cll.2015.
74. Kent ME, Romanelli F (February 2008). "Reexamining syphilis: an
08.004). PMID 26593256 (https://pubmed.ncbi.nlm.nih.gov/265932
update on epidemiology, clinical manifestations, and management".
56).
Annals of Pharmacotherapy. 42 (2): 226–36.
57. Halperin JJ (2015). "Nervous System Lyme Disease". Clinics in doi:10.1345/aph.1K086 (https://doi.org/10.1345%2Faph.1K086).
Laboratory Medicine. 35 (4): 779–95. doi:10.1016/j.cll.2015.07.002 PMID 18212261 (https://pubmed.ncbi.nlm.nih.gov/18212261).
(https://doi.org/10.1016%2Fj.cll.2015.07.002). PMID 26593257 (http S2CID 23899851 (https://api.semanticscholar.org/CorpusID:238998
s://pubmed.ncbi.nlm.nih.gov/26593257). 51).
58. Barbour, Alan G. (2017). "Relapsing Fever". In Kasper, Dennis L.; 75. Hook EW (2017). "Syphilis". Lancet. 389 (10078): 1550–1557.
Fauci, Anthony S. (eds.). Harrison's Infectious Diseases (3rd ed.). doi:10.1016/S0140-6736(16)32411-4 (https://doi.org/10.1016%2FS
New York: McGraw Hill Education. pp. 678–687. ISBN 978-1-259- 0140-6736%2816%2932411-4). PMID 27993382 (https://pubmed.n
83597-1. cbi.nlm.nih.gov/27993382). S2CID 208793678 (https://api.semantic
59. Cutler SJ (2015). "Relapsing Fever Borreliae: A Global Review". scholar.org/CorpusID:208793678).
Clinics in Laboratory Medicine. 35 (4): 847–65. 76. Zhou D, Han Y, Yang R (2006). "Molecular and physiological
doi:10.1016/j.cll.2015.07.001 (https://doi.org/10.1016%2Fj.cll.2015. insights into plague transmission, virulence and etiology". Microbes
07.001). PMID 26593261 (https://pubmed.ncbi.nlm.nih.gov/265932 Infect. 8 (1): 273–84. doi:10.1016/j.micinf.2005.06.006 (https://doi.o
61). rg/10.1016%2Fj.micinf.2005.06.006). PMID 16182593 (https://pubm
60. Atkinson, William (May 2012). Tetanus Epidemiology and ed.ncbi.nlm.nih.gov/16182593).
Prevention of Vaccine-Preventable Diseases (https://www.cdc.gov/v 77. Wagle PM. (1948). "Recent advances in the treatment of bubonic
accines/pubs/pinkbook/tetanus.html) (12 ed.). Public Health plague". Indian J Med Sci. 2: 489–94.
Foundation. pp. 291–300. ISBN 9780983263135. Archived (https://
78. Meyer KF. (1950). "Modern therapy of plague". JAMA. 144 (12):
web.archive.org/web/20150213010501/http://www.cdc.gov/vaccine
982–5. doi:10.1001/jama.1950.02920120006003 (https://doi.org/10.
s/pubs/pinkbook/tetanus.html) from the original on 13 February 1001%2Fjama.1950.02920120006003). PMID 14774219 (https://pu
2015. Retrieved 12 February 2015.
bmed.ncbi.nlm.nih.gov/14774219).
61. "Diphtheria vaccine" (https://bojadla.edu.pl/b/wer8103.pdf) (PDF).
Wkly Epidemiol Rec. 81 (3): 24–32. 20 January 2006.
PMID 16671240 (https://pubmed.ncbi.nlm.nih.gov/16671240).
79. Kilonzo BS, Makundi RH, Mbise TJ (1992). "A decade of plague 80. Bubeck SS, Dube PH (September 2007). "Yersinia pestis
epidemiology and control in the Western Usambara mountains, CO92ΔyopH Is a Potent Live, Attenuated Plague Vaccine" (https://w
north-east Tanzania". Acta Tropica. 50 (4): 323–9. ww.ncbi.nlm.nih.gov/pmc/articles/PMC2043315). Clin. Vaccine
doi:10.1016/0001-706X(92)90067-8 (https://doi.org/10.1016%2F00 Immunol. 14 (9): 1235–8. doi:10.1128/CVI.00137-07 (https://doi.or
01-706X%2892%2990067-8). PMID 1356303 (https://pubmed.ncbi. g/10.1128%2FCVI.00137-07). PMC 2043315 (https://www.ncbi.nlm.
nlm.nih.gov/1356303). nih.gov/pmc/articles/PMC2043315). PMID 17652523 (https://pubme
d.ncbi.nlm.nih.gov/17652523).
81. Bernstein H, Bernstein C, Michod RE (2018). Sex in microbial
pathogens. Infection, Genetics and Evolution volume 57, pages 8-
25. https://doi.org/10.1016/j.meegid.2017.10.024
External links
Bacterial Pathogen Pronunciation (http://www.atsu.edu/faculty/chamberlain/Website/studio.htm) by Neal R. Chamberlain, Ph.D. at A.T. Still
University
Pathogenic bacteria (http://patricbrc.org) genomes and related information at PATRIC (http://patricbrc.org/), a Bioinformatics Resource Center
funded by NIAID (https://www.niaid.nih.gov/)